🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immune checkpoint inhibitors (ICIs) might induce high grade immune-related ...
Status
Unknown
Location
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM.
Start Date
2019-01-01
Trial ID
NCT04294771
Treatments Being Tested
This phase II/III trial studies how well radiation therapy works when given...
Status
Suspended
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-03-22
Trial ID
NCT01810913
This Phase 3 study evaluates the safety and efficacy of cabozantinib in com...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #208
Start Date
2018-06-10
Trial ID
NCT03755791
Treatments Being Tested
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Status
Recruiting
Location
City of Hope
Start Date
2021-06-22
Trial ID
NCT04802759
This study aimed to explore the efficacy of Atezolizumab Plus Bevacizumab a...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2019-09-01
Trial ID
NCT05261438
The investigators wish to set up a pharmaco-epidemiological cohort within t...
Status
Terminated
Location
CHU de Nîmes
Start Date
2021-10-19
Trial ID
NCT05025514
This is a phase 2 study of investigational drug, durvalumab given in combin...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2016-09
Trial ID
NCT02811497
Treatments Being Tested
The objective of this Phase II, open-label, multicenter, non-randomised con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06692491
Treatments Being Tested
Targeting the PD-L1 pathway with atezolizumab has demonstrated objective re...
Status
Completed
Location
University Hospital Essen
Start Date
2021-10-06
Trial ID
NCT04939480
Treatments Being Tested
The overarching purpose of this study is to improve precision medicine thro...
Status
Terminated
Location
Karolinska University Hospital
Start Date
2023-07-01
Trial ID
NCT05742269
Treatments Being Tested